e couldn't previously cover efficiently. KCP will remain a core focus of mine, but they need to build a stronger pipeline. Losing a mandate to sell Virage was a setback there. CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0061198 CONFIDENTIAL SDNY_GM_00207382 EFTA01369106

e couldn't previously cover efficiently. KCP will remain a core focus of mine, but they need to build a stronger pipeline. Losing a mandate to sell Virage was a setback there. CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0061225 CONFIDENTIAL SDNY_GM_00207409 EFTA01369122

and consumer risk quite well and like yield. We show them all ISG fund offerings and expect to focus on Harvest in O1. They were very interested in Virage, but our mandate there fell apart. They are also highly underexposed to public equities and looking to catch up. However, there is a debate between

From: Stewart Oldfield [ Sent: 7/5/2017 5:46:01 PM To: Matt Glassman [email protected] Subject: RE: Virage--litigation finance [II Let's show to Perspecta Trust as well. They manage money for Paul Montrone From: Matt Glassman Sent: Wednesday, July 05, 2

Classification: For Internal use only Starting to put together a draft list of folks interested in litigation finance/Virage deal potentially. Any of your guys come to mind who have invested in the space previously? Matt Glassman Vice President I Key Client Partners - US

From: Stewart Oldfield Sent: 7/5/2017 5:07:18 PM To: Matt Glassman [[email protected] Subject: RE: Virage--litigation finance [I] Cool. Slome is a guy in NY who manages his family $ (and some external I think) in a fund of funds format. Loves consumer r

e couldn't previously cover efficiently. KCP will remain a core focus of mine, but they need to build a stronger pipeline. Losing a mandate to sell Virage was a setback there. Internal networks — I've worked to further expand my internal network this year. I'm involved in DeutscheTech, which is a glob

e couldn't previously cover efficiently. KCP will remain a core focus of mine, but they need to build a stronger pipeline. Losing a mandate to sell Virage was a setback there. Internal networks — I've worked to further expand my internal network this year. I'm involved in DeutscheTech, which is a glob

From: Matt Glassman Sent: 7/5/2017 5:01:48 PM To: Stewart 0ldfield [[email protected] I Subject: RE: Virage--litigation finance [II Classification: For Internal use only Thanks, that's very helpful. I don't think it necessarily should be positioned as a y

Starting to put together a draft list of folks interested in litigation finance/Virage deal potentially. Any of your guys come to mind who have invested in the space previously? Matt Glassman Vice President I Key Client Partners - US

From: Sent: 7/5/2017 5:05:45 PM To: Stewart Oldfield Subject: RE: Virage--litigation finance (II Classification: For kiln' use only Lets sit down tomorrow morning, we can discuss a bit more. From: Stewart Oldfield Sent

and consumer risk quite well and like yield. We show them all ISG fund offerings and expect to focus on Harvest in O1. They were very interested in Virage, but our mandate there fell apart. They are also highly underexposed to public equities and looking to catch up. However, there is a debate between

e couldn't previously cover efficiently. KCP will remain a core focus of mine, but they need to build a stronger pipeline. Losing a mandate to sell Virage was a setback there. Internal networks — I've worked to further expand my internal network this year. I'm involved in DeutscheTech, which is a glob

n attractive rear panel. In short, it's a looker..." THE TELEGRAPH, MARCH 2011 "..well weighted steering and reassuring front-end grip ensure the Virage is engaging on a demanding road, without detracting from its abilities as a grand tourer. The wonderful V12 sounds fantastic and gives strong pe